Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: The spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy

Journal of Trauma and Acute Care Surgery

Volumn 77, Issue 6, 2014, Pages 811-817

  Moore, Hunter B ^a   Moore, Ernest E ^a   Gonzalez, Eduardo ^a   Chapman, Michael P ^a   Chin, Theresa L ^a   Silliman, Christopher C ^b,c   Banerjee, Anirban ^a   Sauaia, Angela ^a  

^a DENVER HEALTH MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Bonfils Blood Center   (United States)

Author keywords

Antifibrinolytic; Fibrinolysis; Fibrinolysis shutdown; Hyperfibrinolysis; Severe trauma

Indexed keywords

ANTIFIBRINOLYTIC AGENT;

ADULT; CAUSE OF DEATH; CONFERENCE PAPER; EMERGENCY HEALTH SERVICE; ERYTHROCYTE TRANSFUSION; EXSANGUINATION; FEMALE; FIBRINOLYSIS; FIBRINOLYSIS SHUTDOWN; FIBRINOLYTIC THERAPY; HEMORRHAGIC SHOCK; HUMAN; HYPERFIBRINOLYSIS; INJURY SCALE; INJURY SEVERITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; PENETRATING TRAUMA; PHYSIOLOGIC FIBRINOLYSIS; PLASMA TRANSFUSION; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; SURVIVAL TIME; THROMBOELASTOGRAPHY; TISSUE INJURY; TRAFFIC ACCIDENT; TRAUMATIC BRAIN INJURY; INJURY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; FEMALE; FIBRINOLYSIS; HUMANS; INJURY SEVERITY SCORE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; THROMBELASTOGRAPHY; WOUNDS AND INJURIES;

EID: 84918534965     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0000000000000341     Document Type: Conference Paper

References (33)

1. Fearnley GR. Fibrinolysis. Ann R Coll Surg Engl. 1967;41(1):51-54.
2. Chakrabarti R, Hocking ED, Fearnley GR. Reaction pattern to three stressesVelectroplexy, surgery, and myocardial infarctionVof fibrinolysis and plasma fibrinogen. J Clin Pathol. 1969;22(6):659-662.
3. Griffiths NJ. Factors affecting the fibrinolytic response to surgery. Ann R Coll Surg Engl. 1979;61(1):12-16.
4. Starzl TE, Marchioro TL, Vonkaulla KN, Hermann G, Brittain RS, Waddell WR. Homotransplantation of the liver in humans. Surg Gynecol Obstet. 1963;117:659-676.
5. Groth CG, Pechet L, Starzl TE. Coagulation during and after orthotopic transplantation of the human liver. Arch Surg. 1969;98(1):31-34.
6. Kashuk JL, Moore EE, Sawyer M,Wohlauer M, Pezold M, Barnett C, Biffl WL, Burlew CC, Johnson JL, Sauaia A. Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma. Ann Surg. 2010; 252(3):434-442; discussion 443-444.
7. Brohi K, Cohen MJ, Davenport RA. Acute coagulopathy of trauma: mechanism, identification and effect. Curr Opin Crit Care. 2007;13(6): 680-685.
8. Ives C, Inaba K, Branco BC, Okoye O, Schochl H, Talving P, Lam L, Shulman I, Nelson J, Demetriades D. Hyperfibrinolysis elicited via thromboelastography predicts mortality in trauma. J Am Coll Surg. 2012; 215(4):496-502.
9. Cotton BA, Harvin JA, Kostousouv V, Minei KM, Radwan ZA, Schöchl H, Wade CE, Holcomb JB, Matijevic N. Hyperfibrinolysis at admission is an uncommon but highly lethal event associated with shock and prehospital fluid administration. J Trauma Acute Care Surg. 2012;73(2):365-370; discussion 370.
10. Schöchl H, Frietsch T, Pavelka M, Jámbor C. Hyperfibrinolysis after major trauma: differential diagnosis of lysis patterns and prognostic value of thrombelastometry. J Trauma. 2009;67(1):125-131.
11. CRASH-2 Trial Collaborators, Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376(9734):23-32.
12. Napolitano LM, Cohen MJ, Cotton BA, Schreiber MA, Moore EE. Tranexamic acid in trauma: how should we use it? J Trauma Acute Care Surg. 2013;74(6):1575-1586.
13. Bozzette A, Aeron-Thomas A. Reducing trauma deaths in the UK. Lancet. 2013;382(9888):208.
14. Chin TL, Moore EE, Moore HB, Gonzalez E, Chapman MP, Stringham JR, Ramos CR, Banerjee A, Sauaia A. A principal component analysis of postinjury viscoelastic assays: clotting factor depletion versus fibrinolysis. Surgery. 2014. In press.
15. Kutcher ME, Ferguson AR, Cohen MJ. A principal component analysis of coagulation after trauma. J Trauma Acute Care Surg. 2013;74(5): 1223-1229; discussion 1229-1230.
16. Yukizawa Y, Inaba Y, Watanabe S, Yajima S, Kobayashi N, Ishida T, Iwamoto N, Choe H, Saito T. Association between venous thromboembolism and plasma levels of both soluble fibrin and plasminogen-Activator inhibitor 1 in 170 patients undergoing total hip arthroplasty. Acta Orthop. 2012;83(1):14-21.
17. Hayakawa M, Sawamura A, Gando S, Jesmin S, Naito S, Ieko M. A low TAFI activity and insufficient activation of fibrinolysis by both plasmin and neutrophil elastase promote organ dysfunction in disseminated intravascular coagulation associated with sepsis. Thromb Res. 2012;130(6):906-913.
18. Chapman MP, Moore EE, Ramos CR, Ghasabyan A, Harr JN, Chin TL, Stringham JR, Sauaia A, Silliman CC, Banerjee A. Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapy. J Trauma Acute Care Surg. 2013;75(6):961-967; discussion 967.
19. Schisterman EF, Perkins NJ, Liu A, Bondell H. Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples. Epidemiology. 2005;16(1):73-81.
20. Raza I, Davenport R, Rourke C, Platton S, Manson J, Spoors C, Khan S, De'Ath HD, Allard S, Hart DP, et al. The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost. 2013;11(2): 307-314.
21. Kutcher ME, Cripps MW, McCreery RC, Crane IM, Greenberg MD, Cachola LM, Redick BJ, Nelson MF, Cohen MJ. Criteria for empiric treatment of hyperfibrinolysis after trauma. J Trauma Acute Care Surg. 2012;73(1):87-93.
22. Schöchl H, Cadamuro J, Seidl S, Franz A, Solomon C, Schlimp CJ, Ziegler B. Hyperfibrinolysis is common in out-of-hospital cardiac arrest: results from a prospective observational thromboelastometry study. Resuscitation. 2013;84(4):454-459.
23. Kluft C, Verheijen JH, Jie AF, Rijken DC, Preston FE, Sue-Ling HM, Jespersen J, Aasen AO. The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-Acting inhibitor of tissue-type plasminogen activator after trauma. Scand J Clin Lab Invest. 1985;45(7):605-610.
24. Kassis J, Hirsh J, Podor TJ. Evidence that postoperative fibrinolytic shutdown is mediated by plasma factors that stimulate endothelial cell type I plasminogen activator inhibitor biosynthesis. Blood. 1992;80(7):1758-1764.
25. Plow EF, Doeuvre L, Das R. So many plasminogen receptors: why? J Biomed Biotechnol. 2012;2012:141806.
26. Bachofen M, Weibel ER. Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clin Chest Med. 1982;3(1):35-56.
27. Idell S, Koenig KB, Fair DS, Martin TR, McLarty J, Maunder RJ. Serial abnormalities of fibrin turnover in evolving adult respiratory distress syndrome. Am J Physiol. 1991;261(4 Pt 1):L2400-L2408.
28. Ostrowski SR, Berg RM,Windeløv NA, Meyer MA, Plovsing RR, Møller K, Johansson PI. Discrepant fibrinolytic response in plasma and whole blood during experimental endotoxemia in healthy volunteers. PLoS One. 2013;8(3):e59368.
29. Ogston D, Ogston CM, Ratnoff OD, Forbes CD. Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors. J Clin Invest. 1969;48(10):1786-1801.
30. Gando S, Nakanishi Y, Tedo I. Cytokines and plasminogen activator inhibitor-1 in posttrauma disseminated intravascular coagulation: relationship to multiple organ dysfunction syndrome. Crit Care Med. 1995; 23(11):1835-1842.
31. Schneeweiss S, Seeger JD, Landon J, Walker AM. Aprotinin during coronary-Artery bypass grafting and risk of death. N Engl J Med. 2008; 358(8):771-783.
32. Asakura H, Ontachi Y, Mizutani T, Kato M, Saito M, Kumabashiri I, Morishita E, Yamazaki M, Aoshima K, Nakao S. An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation. Crit Care Med. 2001;29(6):1164-1168.
33. Hardaway RM, Harke H, Tyroch AH,Williams CH,VazquezY, Krause GF. Treatment of severe acute respiratory distress syndrome: a final report on a phase I study. Am Surg. 2001;67(4):377-382.